SMW Free Realtime Trade Alerts -- Our Last 2 Trade Alerts were VII and NFEC, easy 40-75% wins in minutes, Join Today for FREE!!
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
Loading NWBO News...
Health Technology » Biotechnology
|GILD||Gilead Sciences, Inc.||-2.25%||79.41||1.6%||$919.01m|
|REGN||Regeneron Pharmaceuticals, Inc.||3.43%||425.12||3.1%||$322.43m|
|ALXN||Alexion Pharmaceuticals, Inc.||-1.38%||128.60||2.6%||$246.49m|
|BMRN||BioMarin Pharmaceutical Inc.||1.24%||99.42||3.9%||$225.58m|
|VRTX||Vertex Pharmaceuticals Incorporated||0.82%||97.00||1.7%||$134.70m|
|EXAS||Exact Sciences Corporation||0.35%||17.38||28.8%||$111.63m|
|JUNO||Juno Therapeutics, Inc.||3.41%||30.93||7.9%||$107.19m|
|A||Agilent Technologies, Inc.||1.26%||48.11||1.9%||$84.25m|
Northwest Biotherapeutics, Inc. is a development stage company which is engaged in the development and discovery of innovative immunotherapy products to treat cancer. It has developed a platform technology, DCVax, which uses activated dendritic cells to mobilize a patient's own immune system to attack their cancer. The company was founded by Alton L. Boynton on March 18, 1996 and is headquartered in Bethesda, MD.